Kutoh E, Ongenae N, Claeskens A, Verheyen W, Cheyns P, Neefs J, Kaijen P
Department of Biochemistry, Division of Endocrinology and Metabolism, Janssen Research Foundation, Turnhoutseweg 30, B-2340, Beerse, Belgium.
Mol Cell Endocrinol. 2000 Jul 25;165(1-2):85-95. doi: 10.1016/s0303-7207(00)00262-8.
The authors previously reported that one of the cAMP-response elements (CREs) of the human beta3-AR gene, beta3CRE2, interacts with a nuclear factor which is distinct from CREB/ATF family. We named this factor WATSF-1 (white adipose tissue specific factor-1) since it is preferentially expressed in WAT. In this work, we have shown the absence of DNA binding or transcriptional activity of this factor in several non-adipose cells tested. By computer analysis, beta3CRE2 was found to constitute an octameric element that is highly homologous to the binding site for some members of the nuclear hormone receptor superfamily. Using the response elements of other adipocyte-specific nuclear receptors as competitors, a 'cross-talk' between WATSF-1 and these response elements has been demonstrated. However, the affinity of WATSF-1 for these response elements differs from that for beta3CRE2 (self), implying that WATSF-1 is distinct from these adipocyte-specific nuclear receptors. Furthermore the DNA-binding activity of WATSF-1 was shown to be enhanced by phosphatase treatment, suggesting that phosphorylation may play an important role in the functional modulation of this factor. In an effort to prove that it is indeed an adipocyte-specific factor, we used 3T3-L1 cells, a cellular model of WAT, that can undergo differentiation into adipocytes. The DNA binding and transcriptional activity of this factor appeared during differentiation of the cells. Taken together, these results demonstrate that WATSF-1 is a putative white adipocyte-specific nuclear orphan receptor induced during adipogenesis and is a transcriptional activator through one of the CREs of the human beta3-AR gene. Targeting this factor may be a novel therapeutic approach to stimulation of the beta3-AR signal transduction pathway in adipose tissues.
作者之前报道,人类β3-肾上腺素能受体(β3-AR)基因的一个环磷酸腺苷反应元件(CRE),即β3CRE2,与一种不同于CREB/ATF家族的核因子相互作用。我们将该因子命名为WATSF-1(白色脂肪组织特异性因子-1),因为它在白色脂肪组织中优先表达。在这项研究中,我们发现在所检测的几种非脂肪细胞中,该因子不存在DNA结合或转录活性。通过计算机分析,发现β3CRE2构成了一个八聚体元件,与核激素受体超家族某些成员的结合位点高度同源。使用其他脂肪细胞特异性核受体的反应元件作为竞争者,已证明WATSF-1与这些反应元件之间存在“串扰”。然而,WATSF-1对这些反应元件的亲和力与对β3CRE2(自身)的亲和力不同,这意味着WATSF-1不同于这些脂肪细胞特异性核受体。此外,磷酸酶处理可增强WATSF-1的DNA结合活性,表明磷酸化可能在该因子的功能调节中起重要作用。为了证明它确实是一种脂肪细胞特异性因子,我们使用了3T3-L1细胞,这是一种白色脂肪组织的细胞模型,可分化为脂肪细胞。该因子的DNA结合和转录活性在细胞分化过程中出现。综上所述,这些结果表明WATSF-1是一种推测的白色脂肪细胞特异性核孤儿受体,在脂肪生成过程中被诱导,并且是通过人类β3-AR基因的一个CRE发挥作用的转录激活因子。靶向该因子可能是刺激脂肪组织中β3-AR信号转导途径的一种新型治疗方法。